Gene Expression-Based Signature Can Predict Sorafenib Response in Kidney Cancer.
Gudkov A, Shirokorad V, Kashintsev K, Sokov D, Nikitin D, Anisenko A, Borisov N, Sekacheva M, Gaifullin N, Garazha A, Suntsova M, Koroleva E, Buzdin A, Sorokin M.
Gudkov A, et al. Among authors: sorokin m.
Front Mol Biosci. 2022 Mar 14;9:753318. doi: 10.3389/fmolb.2022.753318. eCollection 2022.
Front Mol Biosci. 2022.
PMID: 35359606
Free PMC article.